Ligand-protein interactions are essential for biological processes, and precise characterization of protein binding sites is crucial to understand protein functions.
Introduction
The use of the protein sequence is the simplest approach to infer by analogy a protein function, e.g., PSI-BLAST [1] . In this research area, PROSITE is a recognized method, distinguishing protein family members from unrelated proteins [2, 3] .
PROSITE patterns represent conserved motifs such as binding site regions. The PROSITE database scans sequences from the annotated UniProtKB / Swiss-Prot database [4, 5] and detects functional domains. Numerous other approaches exist, such as Pfam which uses a refined database of well-characterized protein domain families [6, 7] . The development of so many methods has led to the creation of metaservers that measure consensus across multiple approaches, e.g., JAFA [8] .
Functional protein properties can also be characterized in terms of threedimensional (3D) structural information. This provides valuable information for determining and understanding precise mechanisms of proteins implicated in diseases [9] [10] [11] . The combination of knowledge from 3D protein structures with hundreds of thousands of small-molecules can be used for structure and ligand-based drug design [12] [13] [14] [15] [16] [17] . For example, Crespo and Fernandez used the protein structure of a imatinibresistant mutant [18] to improve the anticancer drug by promoting stronger intermolecular non-bonded interactions than those bound by the original drug. In the same way, the resolution of the HIV-1 reverse transcriptase complex structure explained the potential application of anti-HIV drugs against resistance mutations. It also provided opportunities for understanding, with greater accuracy, inhibitorinserm-00458093, version 1 -19 Feb 2010 protein interactions and to determine reliably the structural effects of resistance mutations [19] .
The Protein Data Bank (PDB [20, 21] ) gathers today more than 59000 protein structures. About 3000 protein structures are not associated with a function. Proteins can be classified according to their folds [22] [23] [24] , e.g., SCOP (Structural Classification of Proteins) [25, 26] . From simple structural classification of protein, these methods have become useful tools to infer protein structures functions and to detect functional relationships, e.g. SCOP is now coupled with BLAST, while PSI-BLAST and RPS-BLAST are associated with Pfam domain search [1, 6, 27] , even PROSITE motifs are now analyzed in 3D structures [28] .
However, a limitation of these classifications is their use of complete protein folds or protein domains. Similarity of fold does not imply a direct similarity of function. For example, the TIM Barrel fold is an alternation of eight -helices and eight parallel -strands along with the peptide backbone. It is ancient [29] and shared by many different enzymes associated with at least 15 different functions [30] . In SCOP, all such proteins are associated with the same cluster.
It is now established that looking specifically at the protein interactions can clarify biological functions, i.e., ligand-protein and protein-protein interactions.
Ligand-protein interactions are at the basis of many fundamental biological processes.
It is also known that the activity of a protein is mediated by a small, highly conserved set of residues within the binding site [31, 32] . Consequently, being able to detect and compare binding sites is valuable for the assignment of predicted structural functional annotations.
During recent years, various methods to compare binding sites have been elaborated, based on diverse types of descriptor. The general aim is to create inserm-00458093, version 1 -19 Feb 2010 automated functional annotation methods independent from amino acid sequence or fold similarity.
Existing methods share common features. CavBase is based on the use of pseudo-centers, i.e., 3D patterns corresponding to chemical properties of amino acids at the surface of proteins [33] . It detects related cavities using a clique detection algorithm. Site similarity ranking occurs according to property-based surface patches shared by the clique solutions. CavBase was used to predict unexpected drug crossreactivity among functionally unrelated target proteins [34] [35] [36] . CavBase is restricted to cavity comparisons.
Like CavBase, SiteEngine [37, 38] also uses pseudo-centers. In SiteEngine, they are gathered into triangles which constitute vertices of graphs. The web version of the approach only enables the comparison of a single site versus another protein structure [39] .
Other methods exist, including FLAP [40] , CPASS [41] and eF-seek [42, 43] ).
Some enable the automatic creation of 3D motifs associated with binding sites for given type of ligands [44] or detect structural similarity to assign E.C. number [43] .
While others, use the detection of conserved residues to characterise binding sites. In this field the Evolutionary Trace method is the most widespread [45] [46] [47] . For example, it was used to identify residue positions important in diverse GPCRs [48] and this method bypasses the need for experimental knowledge of the catalytic mechanism [49] . Thornton"s group maintain the Catalytic Site Atlas (CSA), containing assigned catalytic residues, and gives an additional homologous set, with annotations inferred by PSI-BLAST and sequence alignment to the original set [31] .
George and co-workers used the CSA to identify and segregate related proteins into those with a functional similarity and those where function differs [50] . ProFunc is a inserm-00458093, version 1 -19 Feb 2010 metaserver using both sequence and structure prediction, although it does not provide any simple consensus output to use its results [51] [52] [53] [54] . Roterman"s approach is innovative. It detects regions of significantly irregular hydrophobicity distribution in proteins which appear to be associated with specific functions [55] [56] [57] [58] . They propose a method to detect binding sites based on the hydrophobic distribution analysis in protein structures [59] .
All methods cited above can be used to annotate protein structures. CPASS [41] and SiteEngine [37] were presented with examples of functional annotation for hypothetical protein structures while CavBase [33] and Gilbert and co-workers [44] illustrate their methods by classifying a protein structure dataset. Indeed, these types of classification are particularly relevant as they are not based on global fold alone.
They provide structural functional classifications that can highlight links between proteins and that could be a good start for assigning predicted protein functions to hypothetical proteins.
In this research area, SuMo is a powerful technology to match similar local regions on protein surfaces [60] . Each chemical interactions of a amino acid residue is represented by a pseudo-center, named a Surface Chemical Feature (SCF) (see figure   1 ). These are gathered into triangles, the SuMo graph vertices. SCFs have heterogeneous geometrical properties, and these triangles have specific formation and superimposition rules (distance, angle), so the comparison heuristic is very fast. The comparison of a 3D motif against all binding sites of the PDB can be performed in a few minutes. The first demonstration of SuMo was the assignment of functional and non-functional lectins with a selectivity of 96% [61] . MED-SuMo is the latest evolution of the SuMo software developed by MEDIT [62] In this study, we present the classification of all purine binding sites of the PDB and demonstrate a method to enrich the clusters with purine binding protein structures not co-crystallized with any ligands. Protein kinase distribution in the clusters is analyzed in the discussion section.
Results
Distinct functions can be underlined by the fact that two proteins interact differently with the same class of molecules. MED-SuMo can differentiate these proteins" binding sites. For example, no structural or functional similarities are detected between an actin protein bound to ATP (PDB code: 1S22) and a myosin protein bound to ATP (PDB code: 1FMW) [60, 61, 63, 64] . The classification tool MED-SMA was implemented to use this ability to classify datasets of binding sites inserm-00458093, version 1 -19 Feb 2010 [63] . It operates through three main steps: (i) comparison of all the binding sites of a dataset using a pairwise comparison system, (ii) detection of matching regions in the binding sites to build a similarity graph, and (iii) classification of this graph with the Markov Clustering algorithm (MCL) [65] . This clustering algorithm detects densely populated regions of the similarity graph associated with highly scored matching regions and gathers the similar sub-sites into clusters. 
MED-Sumo Cluster 4.
The N eq equals 14.92 indicating it is a very heterogeneous cluster. It contains 27 different functions. Mostly, they are epimerases, dehydratases and dehydrogrenases, e.g., hydroxysteroid dehydrogrenases, the cluster binds NAD except protein Arna (PDB code 1Z7E [70] ) which binds ATP. Figure 3 shows a 3D superimposition of a dTDP-D-glucose 4,6-dehydratase (PDB code 1KEP Since this classification method is able to group binding site with similar sub pockets, we notice that this cluster is due to the left hand background sub pocket which is shared by functionally different proteins. This cluster also contains a protein annotated as "hypothetical protein" (code PDB 2D1Y). A recent study showed how MED-SuMo could help establish potential functions of proteins [64] . Here, a function corresponds better with a functional mechanism used by the protein to express its The fact that many functions are in this cluster underlines that the binding of a phosphate ligand is not specific to one type of function. It is very common for the mechanism of transport through membrane proteins to require the energy of the phosphate transfer. Here we can say that despite the fact that there are many functions in that cluster, all proteins structures use a similar binding mode, characterized by MED-cluster 33. As for the previous presented cluster, here also, these proteins belong to the same SCOP family, ABC transporter ATPase domain-like (c.37.1.12).
As previously observed, they also share a low sequence identity rate (26.2%). Figure   4 shows the methodology can highlight that the common binding part of this family is on the phosphate side of binding site, and is directly linked to function. binding site is, as for MED-SuMo cluster 33, the phosphate side. Hence, our analysis underlines this similar behaviour for proteins from the same SCOP family. But, it also highlights that sites from MED-SuMo clusters 33 and 40 are clearly distinct, the first one corresponding to one superfamily and the second to four distinct superfamilies.
A few highly populated clusters also have low N eq value. For instance, cluster 159 has a N eq value of 1.74 and it contains 28 binding sites all from HSP70 proteins.
In reality, its N eq should be 1; but HSP70s are sometimes annotated differently. This verifies the fact that MED-SuMo is able to gather proteins with the same function. The upper part involves 5 clusters, each related to the biggest, cluster 87 which is connected to cluster 40: cluster 70 (N eq =1.6, size=5), cluster 69 (N eq =1.0, size=2) and cluster 78 (N eq =1.0, size=2) are adenylate kinase clusters. Adenylate kinases are phosphotransferase enzymes that catalyze the interconversion of adenine nucleotides.
They play an important role in cellular energy homeostasis [80] . Cluster 87 (N eq =6.5, size=56) also contains adenylate kinase, but also more diverse functions. Different nucleotide kinases are present, e.g., thymidylate kinase or uridylate kinase.
Nevertheless, all those structures are from enzymes that catalyze the phosphate transfer from ATPs to the 5' end of nucleotides. Cluster 176 (N eq =2.3, size=16) contains other nucleotide kinases, e.g. deoxycytidine kinase (68%). Interestingly, these are not natural nucleotides. For example, the human deoxycytidine kinase is responsible for the phosphorylation of a number of clinically important nucleoside analogue pro-drugs [81] .
The lower part of the network incorporates 6 clusters, all connected to cluster 40 except cluster 113. Cluster 138 (N eq =1.0, size=2) is a GTPase cluster. Cluster 228 (N eq =1.0, size=1) is a conserved active site with residues in the GTPase domains common to both signal recognition particle and conjugate receptor [82] . Cluster 28 (Neq=1.9, size=3) is small cluster of DNA polymerase III. The DNA polymerase III holoenzyme is the first enzyme complex involved in prokaryotic DNA replication [83] . 
Discussion
Methods to compare binding sites. The detection of functional sites on protein surface is important for the identification of biological activity. Most protein structures are implicated in, at least, one ligand-protein interaction, and they are implicated in the majority of critical biological processes. However, without known related sequences or structures their detection is difficult [89] . Innovative novel approaches have been proposed, i.e., the use of hydrophobicity distribution on protein structures using the fuzzy oil drop model [59] , the destabilization of limited protein regions [90] , phylogenomic classification of protein sequences [91] or the classification of known protein catalytic sites [92] . Prediction of protein functional sites is an important step in identifying small-molecule interactions for drug discovery [93] and to optimize the drugs targeting these sites [94] . Another valuable application is as a pre-processing step to reduce search space for rigorous computational docking algorithms.
Methods to compare binding sites have been developed using various kinds of structural descriptors, e.g., CavBase uses pseudo-centers, and the strong hypothesis that chemical similarity and activity are linked [95] . In this field, MED-SuMo is an efficient approach based on Surface Chemical Features (SCFs). Each SCF represents a pertinent chemical property and is described with appropriate geometric rules. The search of equivalent binding sites is performed by detecting similar graphs where the vertices represent triangles of SCFs. The specific geometric rules of each SCF enable the heuristic to be fast. So, MED-SuMo offers an interesting and original approach to detect structural and functional similarities between protein binding sites.
Here, it is applied in a clustering approach where ligand environments are
classified. An application to a particular protein family, the purinome, is presented. common patterns or related patterns. Our work also extends the creative works of Kasuya and Thornton made on the 3D-structure analysis of PROSITE patterns [97] .
They found numerous PROSITE patterns with common three-dimensional structure characteristics which could be used to create templates defining 3D functional patterns. Wu and co-workers [98] recently improved on a previous study [99] showing that 3D information is significantly more relevant than PROSITE patterns.
Our work suggests that common and distinct characteristics can be associated with a given pattern and that distinct patterns share common local features. In the same way, our analysis highlights the interest in enriching PROSITE annotations for related protein sequences and structures. Indeed one third of proteins from our dataset are not annotated with PROSITE patterns. We have also demonstrated that this binding site classification can be further enriched by apo-structures. Indeed, MED-SuMo can be used to first detect their binding sites and then SCFs signature can be compared to those within the clusters.
Protein kinase. They play a central role in cell regulation pathways in eukaryotes species [100] . As they represent the second largest drug target family for pharmaceutical companies, a chemogenomics concept, called kinomics [101] has been deeply explored. Although they essentially catalyze the same phosphoryl transfer reaction, they are involved with a remarkable number of different substrates, structures, and cell pathways. Analysis and classification of protein kinases have been made at the genomic sequence level with elegant approaches, such as KinG [102] which allowed the identification of novel kinases as in The most homogeneous cluster of this particular analysis is the MED-cluster 46.
However, it does not contain only one type of kinase: 9 proteins are from the AGC and one from PTK family.
Cluster 211 has a high N eq but a more detailed analysis shows that it is very pure cluster with respect to the Kinome classification. Almost all its binding sites are from two branches of the kinome tree, the PTK and CMGC. Only one other protein is from another small distinct branch between PTK and CMGC (PDB code 2A19 [105] ).
Other members of this kinome family are also found in cluster 157.
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Cluster 157 has a high N eq value, and 59 out of 60 binding sites are from protein kinase. However, they are from 3 different Kinome families (CMGC, TK and CAMK) and from one atypical. Even if their sequences are different (which is why they are in 3 distinct families), their ATP binding sites have strong local structural and functional similarities detected by MED-SMA. To understand the disparity of the protein kinase families in this cluster, the ATP binding site of a cell division kinase 2 (CDK2, PDB code 1B38 [106] ) from the CMGC family was compared with the remainder of cluster 157 using MED-SuMo. Classification of datasets, with or without ligands, follow similar rules. Thus, the classification of protein kinases is often quite similar to the Kinome described by
Manning and co-workers [104] , which is logical as related sequences share functional similarities. Nonetheless, some striking exceptions are grouped in the same cluster, protein structures from different part of the Kinome. This is also logical as MED-SMA clusters local 3D surface similarities and not sequences. Moreover, experimental results support these associations, reflecting functional similarity across the Kinome.
MED-SMA utility. This type of relationship between families is very interesting
and their detection is a direct application for MED-SMA. In this classification, we chose to fix a high MED-SuMo minimal score, (5.5 corresponding to at least 10 superimposable SCFs) in order to obtain functionally pure clusters. Other potential uses for this classification method are: deduction of enzymatic mechanism of poorly studied or newly discovered proteins, or in other cases, protein function deduction.
inserm-00458093, version 1 -19 Feb 2010
Thus, we can validate the assertion that functions can be assigned to unknown proteins by finding which cluster(s) are best matches for the concerned structures.
Matching to clusters rather than single structures will diminish a significant amount of the noise. All described applications are based on a potential presence of better known binding sites in the same cluster. Other applications are planned, a complete protein kinase classification with no ligand type filter. We are also studying the results of a classification of all binding sites of the PDB which is a fairly substantial undertaking.
Link.
One last interesting link is observed between cluster 56 (N eq =1.76, size=12) and cluster 121 (N eq =1, size=2). Cluster 56"s main function is DNA topoisomerase II while cluster 120 contains a "histidine kinase". The link is due to the presence of a "histidine kinase" in cluster 56. A review [109] outlines the fact that similarities are found between diverse ATP binding proteins. In fact, they report that histidine kinases are related to the superfamily GHKL ATPase (Gyrase, Hsp90, Histidine Kinase and MutL). Other studies report that they are inhibited by the same drug, the radicicol. In a previous study [63] , MED-SMA underlines these local similarities by collecting binding sites from these 4 families into a single cluster and illustrates them with a 3D view of their superimpositions around the drug radicicol (see figure 8 of [63] ).
Conclusions
This approach is clearly embedded in the structural genomics field. It is fast and, as noted by Ferrè et al. [110] functional patches associated with a large collection of protein surface cavities can be used to provide functional clues to protein with unknown structures. This observation is relevant to the present study. Thus, MED-
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SMA is an approach that may improve the efficiency and effectiveness of early stage drug discovery steps, involving the initial lead selection, improving poor leads, or, multivariate optimization, as it was used in a previous study [17] . This study demonstrates that MED-SuMo is a particularly well suited tool to both annotate protein structures and to enable structural functional classification. Finally, its effectiveness at dealing with the entire PDB shows that MED-SuMo is well-suited to large-scale applications.
Materials and methods

Protein structure database.
The dataset was built using the PDB [20] . X-ray protein structures cocrystallized with ATP, ADP, AMP, ANP, GTP, GDP, GMP, GNP or NAD were extracted. The final PDB dataset contains 2229 protein structures. To avoid a too large database, we chose to include only one binding site per type of ligand for each structure file. At the end, the MED-SuMo database contains 2,322 binding sites.
The PROSITE database [3] was also considered as it gathers protein domains, families or functional sites through more than 4300 sequence patterns or profiles.
Each ligand name was used as a query to regroup related PROSITE patterns and profiles on the ExPASy website [111] . For example, "ATP" is associated with the pattern PDOC00017. It corresponds to "ATP/GTP-binding site motif A (P-loop)".
The PDB structures containing those patterns or profiles were used to gather a secondary dataset of 3,515 protein structures. As most of purine binding proteins are not co-crystallized with purine ligands, only 880 protein structures are in both datasets.
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MED-SuMo Algorithm. MED-SuMo is designed to localize similar regions associated with a defined function [16, 60, 61, 64] . Its main advantage is to detect binding sites with similar or related binding modes which could not be identified using rigid (or even flexible) superimposition approaches. Its heuristic is based on a 3D representation of macromolecule structures using precise Structural Chemical Features (SCFs). For MED-SuMo, a protein structure is represented by a set of functional groups: unbound hydrogen bond (Hbond) donors or acceptors, accessible sides of aromatic rings and carboxylate groups, primary amide, guanidinium, hydroxyl, imidazole, thioether and thiol groups. Each feature associates its chemical characteristics to precise geometrical properties. MED-SuMo comparison methodology (see figure 1) can be divided into two major steps:
(1) The Graph Formation: SCFs are displayed on the protein structure through a lexicographic analysis of the atoms in the PDB files, i.e., for each residue type, a list of predefined SCFs is specified (see figure 1a) . For example, a phenylalanine is represented by two H-bond acceptors, one H-bond donor, one aromatic and three hydrophobics. Once all SCFs are assigned, their positions and orientations are filtered to discard those likely to be involved in intra protein interactions and those too buried to interact with a potential ligand (see figure 1) . Remaining SCFs are assembled into triangles with specific geometric characteristics e.g. edge sizes, perimeter, angles (see figure 1c) . The triangle network is represented as a graph data structure where triangles are vertices and edges connect adjacent triangles. All graphs are stored in the MED-SuMo database (see figure 1d) . protein kinase (e.g., PDB code 1B38, 1QMZ) are annotated as "TRANSFERASE" in the HEADER field, whereas the MOLECULE field specifies "CELL DIVISION PROTEIN KINASE 2". To evaluate the cluster homogeneity, an entropy-derived function is calculated for each cluster and then globally for the whole classification.
This index is named N eq for "equivalent number of states" [69] . It assesses the conditional equivalent number of the predicted states given the observed states. In our study, it is equivalent to the equivalent number of functions per cluster. First, the entropy of the cluster c, H(c), is computed. Then, the N eq is calculated, its expression is the exponential of Shannon entropy [117] , H(c).
with
Where p(i c ) is the probability of the function i in the cluster c, and F is the count of observed functions. So, N eq (c) varies between 1 (i.e., only one function in the cluster) and F (i.e., each structure function is different). The N eq calculation is made on the MOLECULE fields of all the PDB files which were manually checked extensively and on which a few manual fixes were made.
Average sequence identity has been computed for each cluster thanks to CLUSTALW software [118] .
Classification enrichment.
Our PROSITE dataset is also composed with purine binding protein structures.
It contains 3,515 structures of three types: 1,492 are not co-crystallized with purine ligands, 880 are common to the PDB dataset, and are already included in our clusters and 1,143 are apo-structures (protein structures with no ligands). Apo-structure proteins are hard to study as they require the analysis of their whole surfaces.
Moreover, MED-SMA has only been used with binding sites. However, an interesting functionality of MED-SuMo is that it can deal with whole surfaces and is able to inserm-00458093, version 1 -19 Feb 2010 localize interesting binding regions on full protein surfaces [64] . To do so, MEDSuMo compared the full surface of a protein to a binding site database composed with experimentally defined binding sites from the PDB. As mentioned earlier, the classified MED-SuMo database is made with all purine binding sites from the PDB.
In order to localize purine binding sites on those PROSITE apo-structures and to identify in which cluster they could belong to, we arranged the following enrichment protocol in three steps: (1) 
Implementation.
MED-SuMo server is written in OCaml. This language is suited for large-scale software engineering [117] . External libraries are used, including MLsqlite: a sqlite wrapper for OCaml; zmarshall, a compression file manager; findlib: a package management system for Ocaml.
MED-SuMo is a client-server application and uses a scripting language to process calculations requested by the remote interfaces. A Lua interpreter is embedded in the MED-SuMo code, using the Lua-ML library [119] . SuMo to be distributed across a HPC (High-Performance Computing) cluster.
Ongoing development is concerned with parallelization of the entire classification method.
Software Availability and requirements.
The standard MED-SuMo mode to query 3D interaction surfaces against binding sites databases or full surface databases is commercially available with the MED-SuMo Graphical User Interface. For the moment, MED-SMA is only available in a command line mode for integration with wider workflows. However, a web-based interface was developed to interactively explore the generated clusters. This will be available freely on the internet during the year 2010. MED-SuMo is commercial software, and further information is available at http://www.medit-pharma.com/.
Parties interested in commercial evaluation of this technology can contact MEDIT SA to obtain free temporary licenses (info@medit.fr).
Researcher from the INSERM Institute UMR-S 665 has no financial interests in MEDIT SA and collaborates with this company only for the present project.
Therefore, MEDIT SA has the exclusivity for MED-SuMo sales. 3 elements are superimposed: the protein binding sites, the corresponding cocrystallized ligands, represented in stick and finally, the SCFs that enabled that superimposition. The viewer is an ActiveX control that allows the user to move the structures e. g. rotate, translate to visualize the hits as desired. (2) The result table window: the first line corresponds to the query name and its corresponding SCF signature. All other lines correspond to hits found by MED-SuMo. They are originally sorted by decreasing MED-SuMo score (8 th column). Different elements are accessible, e.g. 2D representation of the co-crystallized ligand, MED-SuMo score, quantity of common SCFs, ligand name, structure header. The most important column contains the list of common SCF between the query and the hits: the SCF signature. Each SCF is represented by a colored rectangle e.g. light blue is for HBond donor, dark blue for positive charges. The most important characteristic of these SCFs is that they each stand for 3D functional similarities. 
